Deborah White

Professor, PhD, FFSc(RCPA)

  • Director, Cancer Program, Cancer
  • 4300 Citations
  • 28 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2020

The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL

Tavakoli Shirazi, P., Eadie, L., Heatley, S., Hughes, T., Yeung, D. & White, D., 18 Feb 2020, In : British Journal of Cancer. 122, 4, p. 455-464 10 p.

Research output: Contribution to journalReview article

2016

The role of Wnt/β-Catenin signaling in normal and malignant hematopoiesis

Sadras, T., D'Andrea, R. & White, D., 2016, In : Journal of blood research & hematologic diseases. 1, p. 1 9 p., 1000103.

Research output: Contribution to journalReview article

2015

OCT1 and imatinib transport in CML: Is it clinically relevant?

Watkins, D. B., Hughes, T. & White, D., 1 Oct 2015, In : Leukemia. 29, 10, p. 1960-1969 10 p.

Research output: Contribution to journalReview article

27 Citations (Scopus)
2014
42 Citations (Scopus)
2011

Optimizing the selection of kinase inhibitors for chronic myeloid leukemia patients

Hiwase, D. K., Yeung, D. T. & White, D. L., 1 Jun 2011, In : Expert Review of Hematology. 4, 3, p. 285-299 15 p.

Research output: Contribution to journalReview article

5 Citations (Scopus)
2009

Predicting the response of CML patients to tyrosine kinase inhibitor therapy

White, D. & Hughes, T., 7 Apr 2009, In : Current Hematologic Malignancy Reports. 4, 2, p. 59-65 7 p.

Research output: Contribution to journalReview article

6 Citations (Scopus)